ADM and Vland Enter Joint Development Agreement for Feed Enzyme Technology
January 18 2018 - 10:00AM
Business Wire
- ADM to open new lab to conduct enzyme
research and development
Archer Daniels Midland Company (NYSE: ADM) and Qingdao Vland
Biotech Group Co., Ltd. today announced a joint development
agreement for the development and commercialization of enzymes for
animal feed applications. In addition to ADM’s research center in
Decatur, Illinois, ADM will open a new U.S. enzyme research and
development lab in California that will directly support activities
being undertaken in the joint development agreement. Vland will
also conduct research and development in its Qingdao research
laboratory, which will be upgraded to a new state-of-the-art
facility.
Under the terms of the agreement, the companies will share
enzyme-producing strains as a basis for the development of feed
enzymes that will improve animal nutrition and health. Products
developed under the agreement will be commercialized by both
companies.
“This agreement and the opening of our new enzyme lab will
significantly enhance our ability to develop products for the
fast-growing enzyme market,” said Todd Werpy, ADM’s chief
technology officer. “The agreement will give our research and
development team access to new enzyme strains, and the new
U.S.-based enzyme research lab will provide us with the resources
to use those strains to develop new, state-of-the-art feed enzymes.
We’re looking forward to adding these capabilities to our already
strong array of animal nutrition products and solutions.”
“This agreement is another important step as we continue to
expand our capabilities in bioactives, including enzymes and novel
ingredients for the food, pharmaceutical and animal feed
industries,” said Vikram Luthar, ADM’s president, bioactives. “We
are continuing to build our portfolio in order to offer complete
and innovative solutions to customers in these exciting and rapidly
growing markets.”
“As a high-tech enterprise focused on enzymes, Vland is
committed to seeking partners around the world to build a global
technological innovation system,” said Vland president Chen Gang.
“This agreement between Vland and ADM to engage in the development
of feed enzymes, and the establishment of new research centers in
the U.S. and Qingdao, are important steps. We are looking forward
to future collaborations and the opportunity to offer effective
solutions to customers in this exciting and rapidly growing
market.”
About Vland
Vland Biotech Inc., is one of the leading biotechnology
companies in China. Based in Qingdao, the company specializes in
four product categories: enzymes, probiotics, vaccines and animal
health products. Vland provides solutions for an ever-expanding
list of industries, including agriculture, animal husbandry,
textile, paper making, household cleaning and detergents, food,
biofuel, environmental protection and more.
About ADM
For more than a century, the people of Archer Daniels Midland
Company (NYSE: ADM) have transformed crops into products that serve
the vital needs of a growing world. Today, we’re one of the world’s
largest agricultural processors and food ingredient providers, with
approximately 32,000 employees serving customers in more than 160
countries. With a global value chain that includes approximately
500 crop procurement locations, 250 ingredient manufacturing
facilities, 38 innovation centers and the world’s premier crop
transportation network, we connect the harvest to the home, making
products for food, animal feed, industrial and energy uses. Learn
more at www.adm.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180118005821/en/
Archer Daniels Midland CompanyMedia
RelationsJackie Anderson312-634-8484media@adm.com
Archer Daniels Midland (NYSE:ADM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Archer Daniels Midland (NYSE:ADM)
Historical Stock Chart
From Mar 2023 to Mar 2024